5-hydroxytryptamine receptor 3D structures: Difference between revisions
Michal Harel (talk | contribs) No edit summary |
Michal Harel (talk | contribs) No edit summary |
||
Line 8: | Line 8: | ||
**[[4iaq]] – hHT1B/cytochrome b562 (mutant) + hydroergotamine <br /> | **[[4iaq]] – hHT1B/cytochrome b562 (mutant) + hydroergotamine <br /> | ||
**[[5v54]] – hHT1B/cytochrome b562 (mutant) + methiothepin <br /> | **[[5v54]] – hHT1B/cytochrome b562 (mutant) + methiothepin <br /> | ||
**[[7c61]] – hHT1B/cytochrome b562 (mutant) + antibody <br /> | |||
**[[6g79]] – hHT1B + guanine nucleotide-binding protein<br /> | **[[6g79]] – hHT1B + guanine nucleotide-binding protein<br /> | ||
Line 14: | Line 15: | ||
**[[6a93]] – hHT2A/cytochrome b562 (mutant) + risperidone <br /> | **[[6a93]] – hHT2A/cytochrome b562 (mutant) + risperidone <br /> | ||
**[[6a94]] – hHT2A/cytochrome b562 (mutant) + zotepine <br /> | **[[6a94]] – hHT2A/cytochrome b562 (mutant) + zotepine <br /> | ||
**[[6wgt]] – hHT2A/cytochrome b562 + hallucinogen <br /> | |||
**[[6wh4]] – hHT2A/cytochrome b562 + agonist<br /> | |||
*5-HT 2B | *5-HT 2B | ||
Line 32: | Line 35: | ||
**[[4pir]] – mHT3A + VHH15 - mouse<br /> | **[[4pir]] – mHT3A + VHH15 - mouse<br /> | ||
**[[6be1]] – mHT3A – Cryo EM<br /> | **[[6be1]] – mHT3A – Cryo EM<br /> | ||
**[[6his]] – mHT3A + | **[[6his]] – mHT3A + drug<br /> | ||
**[[6np0]], [[6w1j]], [[6w1m]], [[6w1y]], [[6y1z]] – mHT3A + drug – Cryo EM<br /> | |||
**[[6dg7]], [[6dg8]], [[6hin]], [[6hio]], [[6hiq]] – mHT3A + serotonin – Cryo EM<br /> | **[[6dg7]], [[6dg8]], [[6hin]], [[6hio]], [[6hiq]] – mHT3A + serotonin – Cryo EM<br /> | ||
**[[6y59]], [[6y5a]], [[6y5b]] – mHT3A (mutant) + serotonin – Cryo EM<br /> | |||
}} | }} | ||
[[Category:Topic Page]] | [[Category:Topic Page]] |